Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 4Phase NA 1

Status

Recruiting 4

Sponsor Class

NIH 2OTHER 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Endocrine 4NET 2CNS 2Thoracic 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 188Neoplasm Metastasis 152Neoplasms 141Leukemia, Myeloid, Acute 139Colorectal Neoplasms 132Breast Neoplasms 122Melanoma 96Ovarian Neoplasms 94Prostatic Neoplasms 89Recurrence 88Multiple Myeloma 84Lung Neoplasms 78Pancreatic Neoplasms 77Glioblastoma 77Squamous Cell Carcinoma of Head and Neck 75Lymphoma, Non-Hodgkin 67Myelodysplastic Syndromes 66Triple Negative Breast Neoplasms 58Glioma 58Stomach Neoplasms 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Endometrial Neoplasms 51Carcinoma, Renal Cell 49Brain Neoplasms 49Small Cell Lung Carcinoma 47Lymphoma, Large B-Cell, Diffuse 46Carcinoma, Hepatocellular 45Lymphoma, B-Cell 42Lymphoma, Follicular 41Sarcoma 40

Interventions

fludarabine phosphate 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Adrenocortical Carcinoma × 90 days × Clear all
NCT06487481 2026-06-05

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
32 enrolled
Endocrine

Adrenocortical Carcinoma

NCT07189403 2026-05-22

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Daiichi Sankyo

Phase 1 Recruiting
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT06041516 2026-03-27

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
70 enrolled
CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡